BIA and ABPI joint statement on Michael Gove letter to EU

Responding to Michael Gove's recent letter to the European Union, the UK BioIndustry Association (BIA) and ABPI said: "Our industry welcomes the proposal by the UK government to extend the arrangements on medicines in Northern Ireland agreed last December for a further year at least until 1 January 2023. A period to enable the MHRA, EMA and all EU27 regulators to work together, and with industry, to agree a common understanding of the protocol is much needed to help resolve all outstanding practical issues on medicines. The guiding principle for this work must be to ensure continued access to medicine and medicinal products across the island of Ireland, and both the UK Government and the EU should take all possible steps to achieve this."